Invictus MD Strategies Corp V.GENE

Primary Symbol: IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

GREY:IVITF - Post by User

Invictus MD Strategies Corp > Investor Relations

<< Previous

Bullboard Posts

Next >>

Comment by ManUnitedon Apr 02, 2019 11:19am

123 Views

Post# 29569945

RE:Investor Relations

Unfortunately, I can only agree with all this. It is incomprehensible to me why a joint stock company does not have at least one single employee who is responsible for questions from investors. Why was Phase 3 not completed as planned in January and why a delay of half a year? With regard to the joint venture with Cana, INVICTUS published on March 7th: "The transaction is anticipated to close on or before March 31, 2019." Dear CEO of INVICTUS, is this just another delay as usual, or has this cooperation done before it has started? Sincerely, a concerned shareholder.

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition